Exela sodium bicarbonate injection recalled due to potential for flying glass
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration, causing glass to fly. Exela has received five reports of injury from flying glass. The drug is used to treat metabolic acidosis.
Related News Articles
Headline
The Environmental Protection Agency May 30 announced its intent to finalize by March 1, 2024, new rules governing emissions from ethylene oxide, the gas…
Headline
In response to questions from AHA and others and informed by testing results, the Food and Drug Administration April 21 announced that health care…
Headline
The Food and Drug Administration today withdrew approval for Makena and its generics, citing a confirmatory study that did not verify clinical benefit.…
Headline
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Headline
The U.S. Food & Drug Administration has issued a Class I recall, the most serious type of recall, for the Arrow MAC Two-Lumen Central Venous Access Kits…
Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…